FDA Amends Antacid Monograph to Streamline Testing Procedures

Summary

The Food and Drug Administration is issuing a final rule to amend the monograph for over-the-counter antacid drug products, deleting parts of the testing procedures in subpart C, as part of its ongoing review of OTC drug products and the Administration's 'Reinventing Government' initiative to streamline government and ease industry and consumer burdens.